Drug Database
Back to search

Japan· JP-2655707N1038

スルコナゾール硝酸塩

A sulconazole product containing スルコナゾール硝酸塩, registered in Japan by 田辺ファーマ, on the national reimbursement list. The same ATC class is registered in 5 of our 19 countries.

On Japan’s NHI price listATC D01AC09

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedスルコナゾール硝酸塩ATCD01AC09REGISTER NO.JP-2655707N1038PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about スルコナゾール硝酸塩Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sulconazole is registered in 5 of 19 countries.

Countries holding a registration under ATC D01AC09 (sulconazole), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 2 of them publish a price we can compare per daily dose
Search sulconazole products by name

Sulconazole · ATC D01AC09

5 / 19 countries

  • Belgiumprice
  • Japan
  • Netherlands
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
スルコナゾール硝酸塩
Manufacturer
田辺ファーマ
Country
Japan (JP)
ATC code
D01AC09
ATC class
Sulconazole
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sulconazole in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sulconazole products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Belgium · Myk-1
  • Luxembourg · Myk-1
  • Netherlands · Myk-1

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d9926862-5935-433b-b46c-55e9b72a2478
GET /v1/drugs/d9926862-5935-433b-b46c-55e9b72a2478?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "１％１ｇ",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "2655707N1038",
  "category": "外用薬",
  "price_yen": 16.6,
  "generic_name": "スルコナゾール硝酸塩",
  "product_name_jp": null,
  "therapeutic_class": "2655",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about sulconazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console